Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Toledo, Jon B.; Zetterberg, Henrik; van Harten, Argonde C.; Glodzik, Lidia; ... Trojanowski, John Q. 2015
add to browser selection
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study van Maurik, Ingrid S; Vos, Stephanie J; Bos, Isabelle; Bouwman, Femke H; ... van der Flier, Wiesje M 2019
add to browser selection
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Mattsson, Niklas; Lönneborg, Anders; Boccardi, Marina; Blennow, Kaj; Hansson, Oskar 2017
add to browser selection
Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient? Frisoni, Giovanni; Hansson, Oskar 2016
add to browser selection
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations Lautner, Ronald; Insel, Philip S; Skillbäck, Tobias; Olsson, Bob; ... Zetterberg, Henrik 2017
add to browser selection
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update Boccardi, Marina; Dodich, Alessandra; Albanese, Emiliano; Gayet-Ageron, Angèle; ... Garibotto, Valentina 2021